Cancer Immunotherapy This year marks a turning point in cancer, as long-sought efforts to unleash the immune system against tumors are paying off—even if the future remains a question mark History’s path is unchartab

First Page		Document Content
Date: 2014-01-24 05:34:59 Bristol-Myers Squibb Ipilimumab Cancer immunotherapy Melanoma Immunotherapy CTLA-4 PD-1 Steven Rosenberg Management of cancer Medicine Cancer treatments Immunology		Cancer Immunotherapy This year marks a turning point in cancer, as long-sought efforts to unleash the immune system against tumors are paying off—even if the future remains a question mark History’s path is unchartab Add to Reading List Source URL: www.virotherapy.eu Download Document from Source Website File Size: 828,97 KB Share Document on Facebook

	A Day in Life at BMS Welcome to A Day in Life at BMS where you will meet leaders from our R&D organization and learn more about research and development at Bristol-Myers Squibb, as well as network with our scientists. To DocID: 1vrK6 - View Document
	NoIN THE Supreme Court of the United States BRISTOL-MYERS SQUIBB COMPANY, PETITIONER, DocID: 1tuCc - View Document
	Bristol-Myers Squibb Co. v. Superior Court of Cal., San Francisco Cty) DocID: 1tut4 - View Document
	September 2003 USA Bristol-Myers Squibb Medical Imaging DocID: 1sKnx - View Document
	May 2003 Bristol-Myers Squibb Medical Imaging 331 Treble Cove Road N. Billerica, Massachusetts 01862 DocID: 1sC8T - View Document